Cancer is a complex and heterogeneous disease and is often described as a disease of the genome. Through advances in the field of sequencing, we have more molecular information than ever before.

The culmination of understanding between cancer biology, genomics, new types of diagnostics, and computational biology is enabling new ways to detect, diagnose and treat cancers at the ‘personalized’ level of the patient.

These advances have created the ability to collect and process larger amounts of data quickly, playing a crucial role in the evolution of cancer research.

Cota Partner Janis Naeve, Ph.D., and special guest, Robert Loberg, Ph.D., Vice President, Lifecycle Leader for Oncology & Genetics at Roche Diagnostics, discuss how technological shifts are impacting precision medicine.

ABOUT COTA ACCESS

The Cota Access webinar series offers in-depth, market-driven discussions from featured founders, thought leaders, and leading executives, exploring cutting-edge business and technology trends that fundamentally impact large enterprises.